Perintah Racun (Pindaan Jadual Ketiga) (No. 2) 2017

(No. 2) 2017.

Jadual Ketiga kepada Akta Racun 1952 dipinda—

(a)

dalam perenggan 1—

(i)

dengan memasukkan sebelum butiran “Amfepramone” butiran yang berikut:

“N-(Adamantan-1-yl)-1-pentyl-1H-indazole-3-carboxamide

(APINACA)

N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-

carboxamide (5F-APINACA)”;

(ii)

dengan memasukkan selepas butiran “Amfepramone” butiran yang berikut:

“N- [(1S) - 1-

(Aminocarbonyl) - 2- methylpropyl] - 1-

(cyclohexylmethyl) 1H-indazole- 3- carboxamide

(AB-CHMINACA)”;

P.U. (A) 426 3

(iii)

dengan memasukkan selepas butiran “Clotiazepam” butiran yang berikut:

“N-{[1-

(Cyclohexylmethyl)-1H-indol-3yl]carbonyl}-3-

methyl-L-valinate (MDMB-CHMICA)”;

(iv)

dengan memasukkan selepas butiran “Ethylamphetamine” butiran yang berikut:

“Ethylone (3,4-Methylenedioxy-N-ethylcathinone)

Ethylphenidate”;

“[1-(5-fluoropentyl)-1H-indol-3-yl](2,2,3,3-

tetrametylcyclopropyl) methanone (XLR-11)”;

“Methiopropamine (MPA)

Methoxetamine (MXE)”;

Methylenedioxypyrovalerone (MDPV)” butiran yang berikut:

“4-Methylethcathinone (4-MEC)

Methyl 2-({[1-(5-fluoropentyl)-1H-indazol-3-

yl]carbonyl}amino)-3- methylbutanoate (5F-AMB)

3-Methylmethcathinone (3-MMC)”;

P.U. (A) 426 4

1H-indol-3-yl)methanone (JWH-018)” butiran yang berikut:

“Para-methyl-4-methylaminorex (4,4’-DMAR)”;

“Pentazocine”

butiran yang berikut:

“Pentedrone (α-methylaminovalerophenone)”; dan

(x)

dengan memasukkan selepas butiran “Pyrovalerone”

butiran yang berikut:

“α-Pyrrolidinovalerophenone (α-PVP)

Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-

carboxylate (5F-PB-22)”; dan

(b)

dalam perenggan 2, dengan memasukkan selepas butiran “Pethidine”

butiran yang berikut:

“Remifentanil”.

Dibuat 15 November 2017

[KKM.R.600-1/1/56; PN(PU2)172/XV]

DATUK SERI DR. S. SUBRAMANIAM

Menteri Kesihatan

P.U. (A) 426 5

POISONS ACT 1952

POISONS (AMENDMENT OF THIRD SCHEDULE) (NO. 2) ORDER 2017

IN exercise of the powers conferred by subsection 30(2)

of the

Poisons Act 1952 [Act 366], the Minister, after consultation with the Poisons Board, makes the following order:

Citation 1.

This order may be cited as the Poisons (Amendment of Third Schedule)

(No. 2) Order 2017.

Amendment of Third Schedule 2.

The Third Schedule to the Poisons Act 1952 is amended—

(a)

in paragraph 1—

(i)

by inserting before the item “Amfepramone” the following items:

“N-(Adamantan-1-yl)-1-pentyl-1H-indazole-3-carboxamide

(APINACA)

N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-

carboxamide (5F-APINACA)”;

(ii)

by inserting after the item “Amfepramone” the following item:

“N-[(1S)-1-

(Aminocarbonyl)-2-methylpropyl]-1-

(cyclohexylmethyl) 1H-indazole- 3- carboxamide (AB-CHMINACA)”;

P.U. (A) 426 6

(iii)

by inserting after the item “Clotiazepam” the following item:

“N-{[1-

(Cyclohexylmethyl)-1H-indol-3yl]carbonyl}-

3-methyl-L-valinate (MDMB-CHMICA)”;

(iv)

by inserting after the item “Ethylamphetamine” the following items:

“Ethylone (3,4-Methylenedioxy-N-ethylcathinone)

Ethylphenidate”;

(v)

by inserting after the item “[1-(5-fluoropentyl)-1H-indol-3-

yl](naphthalen-1-yl) methanone (AM-2201)” the following item:

“[1-(5-fluoropentyl)-1H-indol-3-yl](2,2,3,3-

tetrametylcyclopropyl) methanone (XLR-11)”;

(vi)

by inserting after the item “Methaqualone” the following items:

“Methiopropamine (MPA)

Methoxetamine (MXE)”;

(MDPV)” the following items:

“4-Methylethcathinone (4-MEC)

Methyl 2-({[1-(5-fluoropentyl)-1H-indazol-3-

yl]carbonyl}amino)-3-methylbutanoate (5F-AMB)

3-Methylmethcathinone (3-MMC)”;

yl)methanone (JWH-018)” the following item:

“Para-methyl-4-methylaminorex (4,4’-DMAR)”;

P.U. (A) 426 7

(ix)

by inserting after the item “Pentazocine” the following item:

“Pentedrone (α-methylaminovalerophenone)”; and

(x)

by inserting after the item “Pyrovalerone” the following items:

“α-Pyrrolidinovalerophenone (α-PVP)

Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-

carboxylate (5F-PB-22)”; and

(b)

in paragraph 2, by inserting after the item “Pethidine” the following item:

“Remifentanil”.

Made 15 November 2017

[KKM.R.600-1/1/56; PN(PU2)172/XV]

DATUK SERI DR. S. SUBRAMANIAM

Minister of Health